Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Goette

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Heart Failure Clinics|September 24, 2013
Upstream therapy for atrial fibrillation in heart failureAndreas Goette
Cardiac Electrophysiology Review|November 18, 2003
Pacing to prevent atrial fibrillation after coronary artery bypass grafting. What works, what doesn't: insights from Bachmann's Bundle pacingAndreas Goette
Trends in Cardiovascular Medicine|January 15, 2013
Novel oral anticoagulants for stroke prevention in atrial fibrillation: key trial findings and clinical implicationsAndreas Goette
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 3, 2009
Sudden cardiac death stratification in asymptomatic ventricular preexcitationFrancesco Cantú, Andreas Goette,
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 8, 2008
Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanismsAndreas Goette, Uwe Lendeckel
Journal of Cardiovascular Pharmacology|July 30, 2015
The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?Matthias Hammwöhner, Andreas Goette
Pharmacology & Therapeutics|April 2, 2004
Nonchannel drug targets in atrial fibrillationAndreas Goette, Uwe Lendeckel
Cells|October 23, 2021
Atrial Cardiomyopathy: Pathophysiology and Clinical ConsequencesAndreas Goette, Uwe Lendeckel
Journal of Cardiovascular Pharmacology|July 3, 2008
Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillationMatthias Hammwöhner, Andreas Goette
Herzschrittmachertherapie & Elektrophysiologie|September 26, 2022
[Atrial fibrillation on the intensive care unit : The special prognostic importance of the first manifestation]Andreas Goette, Sybille Brandner
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Heart Failure Clinics|September 24, 2013
Upstream therapy for atrial fibrillation in heart failureAndreas Goette
Cardiac Electrophysiology Review|November 18, 2003
Pacing to prevent atrial fibrillation after coronary artery bypass grafting. What works, what doesn't: insights from Bachmann's Bundle pacingAndreas Goette
Trends in Cardiovascular Medicine|January 15, 2013
Novel oral anticoagulants for stroke prevention in atrial fibrillation: key trial findings and clinical implicationsAndreas Goette
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 3, 2009
Sudden cardiac death stratification in asymptomatic ventricular preexcitationFrancesco Cantú, Andreas Goette,
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 8, 2008
Electrophysiological effects of angiotensin II. Part I: signal transduction and basic electrophysiological mechanismsAndreas Goette, Uwe Lendeckel
Journal of Cardiovascular Pharmacology|July 30, 2015
The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?Matthias Hammwöhner, Andreas Goette
Pharmacology & Therapeutics|April 2, 2004
Nonchannel drug targets in atrial fibrillationAndreas Goette, Uwe Lendeckel
Cells|October 23, 2021
Atrial Cardiomyopathy: Pathophysiology and Clinical ConsequencesAndreas Goette, Uwe Lendeckel
Journal of Cardiovascular Pharmacology|July 3, 2008
Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillationMatthias Hammwöhner, Andreas Goette
Herzschrittmachertherapie & Elektrophysiologie|September 26, 2022
[Atrial fibrillation on the intensive care unit : The special prognostic importance of the first manifestation]Andreas Goette, Sybille Brandner
Pageof 20